County
Oakland County Medical Control Authority (OCMCA)
Oakland County Medical Control Authority (OCMCA) (MI) carries 35 drugs across 118 dose entries in its current published protocol, effective 2026-06-22.
Drugs and doses35
Acetaminophen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 650 mg | PO | not captured | standing | page 169 |
| Pediatric fever | adult | 650 mg | PO | not captured | standing | page 89 |
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Narrow-complex tachycardia | adult | 6 mg | IV | not captured | standing | page 108 |
| Narrow-complex tachycardia | peds | 0.1 mg/kg | IV | not captured | standing | page 108 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 2.5 mg | NEB | not captured | standing | page 16 |
| Anaphylaxis | peds | 2.5 mg | NEB | not captured | standing | page 16 |
| Asthma / bronchospasm | adult | 2.5 mg | NEB | not captured | standing | page 67 |
| Asthma / bronchospasm | peds | 2.5 mg | NEB | not captured | standing | page 67 |
| Crush injury | adult | 2.5 mg | NEB | not captured | standing | page 34 |
| Crush injury | peds | 2.5 mg | NEB | not captured | standing | page 34 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Wide-complex tachycardia | adult | 150 mg | IV | not captured | standing | page 109 |
| Wide-complex tachycardia | peds | 5 mg/kg | IV | not captured | standing | page 109 |
| VF / pulseless VT | adult | 300 mg | IV/IO | not captured | standing | page 104 |
| VF / pulseless VT | peds | 5 mg/kg | IV/IO | not captured | standing | page 104 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 325 mg | PO | not captured | standing | page 112 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 1 mg | IV/IO | not captured | standing | page 106 |
| Bradycardia | peds | 0.02 mg/kg | IV/IO | not captured | standing | page 106 |
| Other | adult | 1 mg | IV/IO | not captured | standing | page 74 |
Calcium Chloride
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Crush injury | adult | 1 g | IV | not captured | standing | page 35 |
| Crush injury | peds | 20 mg/kg | IV | not captured | standing | page 35 |
| Hyperkalemia | adult | 1 g | IV/IO | not captured | standing | page 104 |
| Hyperkalemia | peds | 20 mg/kg | IV/IO | not captured | standing | page 104 |
Cefazolin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2 g | IV | not captured | standing | page 37 |
| Other | adult | 2 g | not captured | not captured | standing | page 37 |
| Other | peds | 30 mg/kg | IV | not captured | standing | page 37 |
| Other | peds | 30 mg/kg | not captured | not captured | standing | page 37 |
Ceftriaxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 2 g | IV | not captured | standing | page 37 |
| Other | adult | 2 g | not captured | not captured | standing | page 37 |
| Other | peds | 50 mg/kg | IV | not captured | standing | page 37 |
| Other | peds | 50 mg/kg | not captured | not captured | standing | page 37 |
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 25 g | IV | not captured | standing | page 27 |
| Other | peds | 0.5 g/kg | IV | not captured | standing | page 27 |
Diazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Procedural sedation | adult | 5–10 mg | IV/IO | not captured | standing | page 183 |
Diltiazem
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Narrow-complex tachycardia | adult | 15–20 mg | IV | not captured | standing | page 109 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 50 mg | IV/IO/IM | not captured | standing | page 17 |
| Allergic reaction | peds | 1 mg/kg | IV/IO/IM | not captured | standing | page 17 |
| Dystonic reaction | adult | 50 mg | IV | not captured | standing | page 43 |
| Dystonic reaction | peds | 1 mg/kg | IV | not captured | standing | page 43 |
| Nausea / vomiting | adult | 12.5–25 mg | IV/IM | not captured | standing | page 11 |
| Nausea / vomiting | peds | 1 mg/kg | IV/IM | not captured | standing | page 11 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 0.3 mg | IM | not captured | standing | page 15 |
| Anaphylaxis | peds | 0.15 mg | IM | not captured | standing | page 15 |
| Hypotension / shock | adult | 10–20 mcg | IV/IO | not captured | standing | page 13 |
| Hypotension / shock | peds | 1 mcg/kg | IV/IO | not captured | standing | page 13 |
| Respiratory distress | adult | 0.3 mg | IM | not captured | standing | page 68 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 1 mcg/kg | IV/IO/IM/IN | not captured | standing | page 113 |
| Mild to moderate pain | peds | 1 mcg/kg | IV/IO/IM/IN | not captured | standing | page 113 |
Hydrocortisone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Adrenal crisis | adult | 100 mg | IV/IM | not captured | standing | page 19 |
| Adrenal crisis | peds | 1–2 mg/kg | IV/IM | not captured | standing | page 19 |
Ibuprofen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 400 mg | PO | not captured | standing | page 169 |
| Pediatric fever | adult | 400 mg | PO | not captured | standing | page 89 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 500 mcg | NEB | not captured | standing | page 16 |
| Anaphylaxis | peds | 500 mcg | NEB | not captured | standing | page 16 |
| Respiratory distress | adult | 500 mcg | NEB | not captured | standing | page 67 |
| Respiratory distress | peds | 500 mcg | NEB | not captured | standing | page 67 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 0.2 mg/kg | IV/IO | not captured | standing | page 170 |
| Mild to moderate pain | adult | 0.5 mg/kg | IN | not captured | standing | page 170 |
| Mild to moderate pain | peds | 0.2 mg/kg | IV/IO | not captured | standing | page 170 |
| Mild to moderate pain | peds | 0.5 mg/kg | IN | not captured | standing | page 170 |
| Procedural sedation | adult | 1.5 mg/kg | IV/IO | not captured | standing | page 183 |
| Procedural sedation | peds | 1.5 mg/kg | IV/IO | not captured | standing | page 183 |
Ketorolac
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 15 mg | IV/IM | not captured | standing | page 169 |
| Mild to moderate pain | peds | 0.5 mg/kg | IV/IM | not captured | standing | page 169 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 20 mg | IO | not captured | standing | page 199 |
| Mild to moderate pain | peds | 0.5 mg/kg | IO | not captured | standing | page 199 |
| Wide-complex tachycardia | adult | 1 mg/kg | IV | not captured | standing | page 109 |
| Wide-complex tachycardia | peds | 1 mg/kg | IV | not captured | standing | page 109 |
| VF / pulseless VT | adult | 1 mg/kg | IV/IO | not captured | standing | page 104 |
| VF / pulseless VT | peds | 1 mg/kg | IV/IO | not captured | standing | page 104 |
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2 g | IV | not captured | standing | page 68 |
| Eclampsia / pre-eclampsia | adult | 4 g | IV/IO | not captured | standing | page 69 |
| VF / pulseless VT | adult | 2 g | IV/IO | not captured | standing | page 104 |
Methylprednisolone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Adrenal crisis | adult | 125 mg | IV/IO/IM | not captured | standing | page 19 |
| Adrenal crisis | peds | 2 mg/kg | IV/IO/IM | not captured | standing | page 19 |
| Anaphylaxis | adult | 125 mg | IV/IO/IM | not captured | standing | page 18 |
| Anaphylaxis | peds | 2 mg/kg | IV/IO/IM | not captured | standing | page 18 |
| Respiratory distress | adult | 125 mg | IV/IO/IM | not captured | standing | page 67 |
| Respiratory distress | peds | 2 mg/kg | IV/IO/IM | not captured | standing | page 67 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperactive delirium | adult | 10 mg | IM/IN | not captured | standing | page 71 |
| Other | adult | 0.1 mg/kg | IM/IN | not captured | standing | page 181 |
| Other | peds | 0.1 mg/kg | IM/IN | not captured | standing | page 181 |
| Procedural sedation | adult | 1–5 mg | IV/IO | not captured | standing | page 183 |
| Procedural sedation | adult | 1–5 mg | IN | not captured | standing | page 183 |
| Procedural sedation | peds | 0.05 mg/kg | IV/IO | not captured | standing | page 183 |
| Procedural sedation | peds | 0.05 mg/kg | IN | not captured | standing | page 183 |
| Seizure | adult | 10 mg | IM | not captured | standing | page 69 |
| Seizure | adult | 5 mg | IV/IO | not captured | standing | page 69 |
| Seizure | adult | 5 mg | IV/IO/IM/IN | not captured | standing | page 69 |
| Seizure | peds | 0.1 mg/kg | IM | not captured | standing | page 91 |
Morphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 172 |
| Mild to moderate pain | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 172 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Opioid overdose | adult | 2 mg | IM/IN | not captured | standing | page 23 |
| Opioid overdose | adult | 2 mg | IV | not captured | standing | page 24 |
| Opioid overdose | peds | 0.1 mg/kg | IM/IN | not captured | standing | page 23 |
| Opioid overdose | peds | 0.1 mg/kg | IV | not captured | standing | page 24 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 0.4 mg | SL | not captured | standing | page 112 |
| Cardiogenic shock | adult | 0.4 mg | SL | not captured | standing | page 111 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 4 mg | ODT | not captured | standing | page 10 |
| Nausea / vomiting | adult | 4 mg | IV/IM | not captured | standing | page 10 |
| Nausea / vomiting | peds | 0.1 mg/kg | IV/IM | not captured | standing | page 10 |
| Nausea / vomiting | peds | 4 mg | ODT | not captured | standing | page 10 |
Oral Glucose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 15 g | PO | not captured | standing | page 27 |
| Other | peds | 15 g | PO | not captured | standing | page 27 |
Prednisone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Adrenal crisis | adult | 50 mg | PO | not captured | standing | page 19 |
| Adrenal crisis | peds | 50 mg | PO | not captured | standing | page 19 |
| Anaphylaxis | adult | 50 mg | PO | not captured | standing | page 17 |
| Anaphylaxis | peds | 50 mg | PO | not captured | standing | page 17 |
| Respiratory distress | adult | 50 mg | PO | not captured | standing | page 67 |
| Respiratory distress | peds | 50 mg | PO | not captured | standing | page 67 |
Racemic Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Stridor | peds | 0.5 mL | NEB | not captured | standing | page 88 |
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperkalemia | adult | 1 mEq/kg | IV/IO | not captured | standing | page 104 |
| Hyperkalemia | peds | 1 mEq/kg | IV/IO | not captured | standing | page 104 |
| Tricyclic overdose | adult | 50 mEq | IV/IO | not captured | standing | page 43 |
| Tricyclic overdose | peds | 1 mEq/kg | IV/IO | not captured | standing | page 43 |
Tetracaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 1–2 drop | not captured | not captured | standing | page 44 |
| Other | peds | 1–2 drop | not captured | not captured | standing | page 44 |
Tranexamic Acid
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Trauma / hemorrhage | adult | 1 g | IV/IO | not captured | standing | page 55 |
Verapamil
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Narrow-complex tachycardia | adult | 5 mg | IV | not captured | standing | page 109 |